Table 1.
Indicators | Group | ||||
---|---|---|---|---|---|
Control | VPAH | NTG | NTG-VPAL | NTG-VPAH | |
MDA (nmol/mg protein) | 10.8 ± 1.9 | 8.5 ± 2.8 | 25.3 ± 6.7*,** | 21.8 ± 4.2*,** | 13.5 ± 3.5***,**** |
GSH (nmol/mg protein) | 8.9 ± 1.2 | 8.4 ± 1.9 | 5.2 ± 0.9*,** | 6.2 ± 1.5* | 8.2 ± 1.5*** |
GSH-x (U/g protein) | 17.8 ± 0.6 | 16.3 ± 3.4 | 7.8 ± 2.0*,** | 10.8 ± 3.0*,** | 15.1 ± 2.1***,**** |
Vitamin A (μmol/g brain) | 3.3 ± 0.7 | 3.2 ± 0.5 | 1.6 ± 0.3*,** | 2.1 ± 0.3*,** | 2.9 ± 0.4***,**** |
Vitamin C (μmol/g brain) | 71.0 ± 16.6 | 69.2 ± 11.7 | 33.8 ± 8.0*,** | 44.0 ± 6.6*,** | 62.5 ± 9.6*** |
Vitamin E (μmol/g brain) | 11.0 ± 1.5 | 11.8 ± 2.0 | 5.8 ± 1.5*,** | 7.4 ± 1.1*,** | 9.0 ± 1.6*** |
“*”, significantly different from the control group, P < 0.05; “**”, significantly different from the VPAH group, P < 0.05; “***”, significantly different from the NTG group, P < 0.05; “****”, significantly different from the NTG-VPAL group, P < 0.05